In8bio Inc (INAB)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 9.83M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 16.71
52W Low
$ 1.98
Dividend Yield
0.00%
Beta
0.02
Technicals
50-Day MA
2.2353
200-Day MA
5.5534
52 Week High
16.71
52 Week Low
1.98
About INAB
IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmu.
Employees
18
Headquarters
New York, NY
CEO
Mr. Tai-Wei Ho